Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2270-2025

DxI 600 Access Immunoassay Analyzer W/Dual Gantry, Part Number A71461 Recall

DxI 600 Access Immunoassay Analyzer W/Dual Gantry, Part Number A71461

FDA recall Class II

Ongoing

FDA lists this Class II recall for DxI 600 Access Immunoassay Analyzer W/Dual Gantry, Part Number A71461. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2270-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 25, 2025
FDA report date
Aug 13, 2025
Quantity in commerce
1 system
Distribution
See key details
FDA cause
Device Design

What is being recalled?

DxI 600 Access Immunoassay Analyzer W/Dual Gantry, Part Number A71461

Affected model & UDI checker

Search the exact identifiers published for Z-2270-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedDxI 600 Access Immunoassay Analyzer W/Dual Gantry, Part Number A71461Check source notice15099590369248
FDA code information

UDI-DI: 15099590369248; Serial Numbers: 902101

View the original FDA recall notice

Why was this product recalled?

Beckman Coulter has identified that the UniCel DxI 600/800 systems with linear slide PnP gantries running software versions 5.7 and up faced incorrect PnP X-motor current settings where the PnP X-motor current incorrectly resets to 1.5A (instead of the required 2.0A) because the software overwrites the factory setting during installs or upgrades. This anomaly causes increased PnP motion errors which could lead to delays in reporting patient sample results if unnoticed.

What actions did BECKMAN COULTER, INC. take?

An URGENT MEDICAL DEVICE RECALL notification dated 6/25/25 was sent to customers. ACTION: If your laboratory encounters any of the events described in this letter: " Perform a system initialization to resume normal operation. o If repeated initialization attempts fail, contact Customer Technical Support. " Repeat testing for any cancelled tests. " No action is required if your laboratory has not observed the events listed above ESOLUTION: "A Beckman Coulter representative will schedule the modification installation when it is available. Please share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter. So that we are assured you have received this important communication, please respond within 10 days in one of the following ways: " Electronically, if you received this communication via email. " Manually, complete and return the enclosed Response Form. If you have any questions regarding this notice, please contact our Customer Support: " From our website: http://www.beckmancoulter.com

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology